| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| Revenue | 49,9 k € | +7.0% | 46,7 k € | -20.5% | 58,7 k € | |
| Gross margin | 3,1 k € | +107.9% | -39,5 k € | -190.0% | -13,6 k € | |
| EBITDA | -6,7 k € | +90.9% | -73,8 k € | -134.3% | -31,5 k € | |
| Operating profit | -44,6 k € | +60.1% | -111,7 k € | -103.5% | -54,9 k € | |
| Profit/loss | -45,1 k € | +60.0% | -112,7 k € | -104.6% | -55,1 k € | |
| Equity | -112,9 k € | -66.5% | -67,8 k € | -251.0% | 44,9 k € | |
| Total assets | 243,8 k € | -21.0% | 308,8 k € | -18.2% | 377,4 k € | |
| Cash | 77,1 € | -96.7% | 2,3 k € | -89.8% | 22,7 k € | |
| Debts | 356,7 k € | -5.3% | 376,6 k € | +13.2% | 332,5 k € | |
Source: Belgian Official Gazette
Private limited company · Mons · incorporated on 03/05/2022
Private limited company loss-making in the latest fiscal year. Cash position declining (-96.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
BRUPHARM PHARMALAB is a Private limited company incorporated in 2022. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mons.